EUVIMEDEUVIMED entdecken
Crossref

Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes

Jenna Schauer iD, Othman A Aljohani iD, Ryan Cantor, Anna Fraser, Firezer Haregu iD, Kyle Hope, James K Kirklin, Consuela Thompson, Simon Urschel, Nadia Zaim, Hong Zhao, Micah S Brosbe iD

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Jenna Schauer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York-Presbyterian Morgan Stanley Children'…. Hauptthemen laut MEDLINE: Heart Transplantation, Psychotropic Drugs. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Pediatric Heart Transplant Society, Enduring Hearts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is increasing recognition of the mental health toll of heart transplant on pediatric transplant patients and their families. Little is known about the use of psychoactive medications in this population.

Methods

The Pediatric Heart Transplant Society (PHTS) collects data on patients pre and post‐transplant including medication use for anxiety, depression, and attention deficit/hyperactivity disorder. We analyzed psychoactive medication use among transplant recipients older than 5 years at follow‐up and assessed for associations with pre‐transplant risk factors and post‐transplant outcomes. A survey about mental health resources was sent to all PHTS sites.

Results

Among 1792 patients older than 5 years at 1 year post transplant, 301 patients (16.8%) were prescribed at least one psychoactive medication, 246 (13.7%) were prescribed antianxiety/antidepressant medications, and 59 (3.3%) were prescribed medications for ADHD. Patients on psychoactive medications at 1 year post transplant tended to be older and more sick at the time of transplant. There was no association between psychoactive medication use on graft loss, coronary artery disease, or rejection at 1‐year post‐transplant; there was a higher incidence of coronary artery disease at 3 years post transplant and increased coronary artery disease and graft loss at 5 years post transplant. Screening instrument usage varied across sites. Mental health providers are typically available for patients but vary with regard to timing and disciplines involved across centers.

Conclusions

A significant proportion of pediatric heart transplant recipients take psychoactive medications. Psychoactive medication usage is associated with worse long‐term outcomes including graft loss and coronary artery disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationPsychotropic DrugsHumansFemaleRisk FactorsChildMaleChild, PreschoolAdolescentPrevalenceTreatment OutcomeAttention Deficit Disorder with HyperactivityGraft RejectionFollow-Up StudiesDepressionAnxietyCoronary Artery Disease

Stichwörter der Autor:innen

coronary artery vasculopathypediatric heart transplantpsychoactive medications

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York-Presbyterian Morgan Stanley Children's Hospital, New York, New York, USA.
  • Division of Pediatric Cardiology, Department of Pediatrics, Benioff Children's Hospital, University of California-San Francisco, San Francisco, California, USA.
  • Kirklin Solutions, Inc., Birmingham, Alabama, USA.
  • Division of Pediatric Cardiology, Department of Pediatrics, University of Virginia Children's Hospital, Charlottesville, Virginia, USA.
  • Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
  • Division of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins Hospital, Bloomberg Children's Center, Blalock-Taussig-Thomas Heart Center, Baltimore, Maryland, USA.

ORCID-Profile: Jenna Schauer, Othman A Aljohani, Firezer Haregu, Micah S Brosbe

Förderung

  • Pediatric Heart Transplant Society
  • Enduring Hearts

Zitieren

APA

Schauer, J., Aljohani, O. A., Cantor, R., Fraser, A., Haregu, F., Hope, K., Kirklin, J. K., Thompson, C., Urschel, S., Zaim, N., Zhao, H., & Brosbe, M. S. (2026). Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes. Pediatric Transplantation. https://doi.org/10.1111/petr.70272

Vancouver

Schauer J, Aljohani OA, Cantor R, Fraser A, Haregu F, Hope K, et al. Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes. Pediatric Transplantation. 2026. doi:10.1111/petr.70272

BibTeX
@article{Schauer2026,
  author = {Schauer, Jenna and Aljohani, Othman A and Cantor, Ryan and Fraser, Anna and Haregu, Firezer and Hope, Kyle and Kirklin, James K and Thompson, Consuela and Urschel, Simon and Zaim, Nadia and Zhao, Hong and Brosbe, Micah S},
  title = {Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70272}
}
Kostenlos starten →